Manuscripts
Showing 1556 manuscripts.
Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2)
Citation
Ram Yogev, Sophia S. Lee, Andrew A. Wiznia, Sharon Appelbaum Nachman, Kenneth Stanley, Stephen Ira Pelton, Lynne M. Mofenson, Susan A. Fiscus, Eleanor Jimenez, Mobeen H. Rathore, Elizabeth (Betsy) Smith, Kenneth McIntosh. Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2). Pediatric Infectious Disease Journal. 2002. 2: 119-25.Year
2002
Journal
Pediatric Infectious Disease Journal
Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission
Citation
Alejandro Dorenbaum, Coleen Cunningham, Richard D. Gelber, Mary Culnane, Lynne M. Mofenson, Paula Britto, Claire Rekacewicz, Marie Louise Newell, Jean-Francois Delfraissy, Bethann Cunningham-Schrader, Mark Mirochnick, John L. Sullivan. Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission. The Journal of the American Medical Association. 2002. 288: 189-198.Year
2002
Journal
The Journal of the American Medical Association
Efavirenz liquid Formulation in human immunodeficiency virus-infected children.
Citation
Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Richard Brundage, Florence H. Yong, Steven D. Douglas, Patricia M. Flynn, Mark W. Kline, Patricia M. Flynn. Efavirenz liquid Formulation in human immunodeficiency virus-infected children.. Pediatric Infectious Disease Journal. 2002. 21: 659-63.Year
2002
Journal
Pediatric Infectious Disease Journal
Concentrations of protease inhibitors in cord blood after in utero exposure.
Citation
Mark Mirochnick, Alejandro Dorenbaum, Diane Holland, Bethann Cunningham-Schrader, Coleen K. Cunningham, Coleen Cunningham, Bethann Cunningham-Schrader, Richard D. Gelber, Lynne M. Mofenson, Mary Culnane, James D. Connor, John L. Sullivan. Concentrations of protease inhibitors in cord blood after in utero exposure.. Pediatric Infectious Disease Journal. 2002. 21: 835-8.Year
2002
Journal
Pediatric Infectious Disease Journal
Age-related expression of naive (CD45RA/62L) and activation (HLADR/CD38) surface markers on CD4+ T-cells in normal children (birth to 18 years)
Citation
William T. Shearer, Howard Max Rosenblatt, Stephen A. Spector, E. Richard Stiehm, Diane W. Wara, Steven D. Douglas, Katherine Luzuriaga, Elizabeth (Betsy) J. McFarland, Ram Yogev, Mobeen H. Rathore, Wende Levy, Barney S. Graham, Rebecca Oyomopito, Rebecca S. Gelman. Age-related expression of naive (CD45RA/62L) and activation (HLADR/CD38) surface markers on CD4+ T-cells in normal children (birth to 18 years). Journal of Allergy and Clinical Immunology. 2002. 109: S199.Year
2002
Journal
Journal of Allergy and Clinical Immunology
Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir
Citation
Mohammed M. Hossain, Jason J. Coull, George Drusano, David M. Margolis. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Research. 2002. 55: 41-52.Year
2002
Journal
Antiviral Research
Adherence to HAART among patients with HIV: breakthroughs and barriers
Citation
Jeannette Ickovics, C.S. Meade. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care. 2002. 14: 309-18.Year
2002
Journal
AIDS Care
CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid
Citation
Peter Anderson, Richard Brundage, Thomas N Kakuda, Courtney V. Fletcher. CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid. Clinical Pharmacology & Therapeutics. 2002. 71: 280-5.Year
2002
Journal
Clinical Pharmacology & Therapeutics
Modelling HIV viral rebound using non-linear mixed effects models
Citation
A. P. Fitzgerald, Victor DeGruttola, Florin Vaida. Modelling HIV viral rebound using non-linear mixed effects models. Statistics In Medicine. 2002. 21: 2093-108.Year
2002
Journal
Statistics In Medicine
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
Citation
Mark Mirochnick, Ellen Rae Cooper, Edmund Capparelli, Kenneth McIntosh, Jane C. Lindsey, Jing Xu, David P. Jacobus, Lynne M. Mofenson, Vincent R. Bonagura, Sharon Appelbaum Nachman, Ram Yogev, John L. Sullivan, Stephen A. Spector. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.. Clinical Pharmacology & Therapeutics. 2001. 70: 24-32.Year
2001
Journal
Clinical Pharmacology & Therapeutics